Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD
Background Prevalence and load of airway bacteria in stable and exacerbated chronic obstructive pulmonary disease (COPD) has been previously studied using microbiological culture. Molecular techniques, such as quantitative PCR (qPCR), may be more informative. Methods In this study, 373 sputum sample...
Saved in:
Published in | Thorax Vol. 67; no. 12; pp. 1075 - 1080 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BMJ Publishing Group Ltd and British Thoracic Society
01.12.2012
BMJ Publishing Group BMJ Publishing Group LTD |
Subjects | |
Online Access | Get full text |
ISSN | 0040-6376 1468-3296 1468-3296 |
DOI | 10.1136/thoraxjnl-2012-201924 |
Cover
Loading…
Abstract | Background Prevalence and load of airway bacteria in stable and exacerbated chronic obstructive pulmonary disease (COPD) has been previously studied using microbiological culture. Molecular techniques, such as quantitative PCR (qPCR), may be more informative. Methods In this study, 373 sputum samples from 134 COPD outpatients were assessed for prevalence and load of typical airway bacteria (Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis) by multiplex qPCR, with 176 samples analysed for atypical bacteria. Paired stable and exacerbation typical bacteria data were compared in 52 patients. We compared routine culture with qPCR in 177/373 samples. Results Typical bacteria were more prevalent in exacerbation than stable-state paired samples: 30/52 (57.7%) vs. 14/52 (26.9%); p=0.001. In patients who were bacteria-positive at both time points, mean (±1 SEM) load was significantly higher at exacerbation than stable state (108.5(±0.3) vs. 107.2(±0.5) cfu/ml), constituting a 20-fold increase (p=0.011). qPCR was more discriminatory at detecting typical bacteria than microbiological culture (prevalence 59.3% vs. 24.3%; p<0.001). At stable state, higher airway bacterial load correlated with more severe airflow limitation (FEV1%predicted) (r=−0.299; p=0.033) and higher inhaled corticosteroid dosage (r=0.382; p=0.008). Mean C-reactive protein was higher in bacterial-associated exacerbations (35.0 Vs 25.1 mg/L; p=0.032). Conclusions Airway bacterial prevalence and load increase at COPD exacerbations and are an aetiological factor. qPCR is more discriminatory than culture, identifying higher airway bacterial prevalence. Exacerbations associated with bacterial detection showed a higher mean C-reactive protein level. In the stable state, airway bacterial load is related to more severe airflow limitation and higher inhaled corticosteroid dosage used. |
---|---|
AbstractList | Background Prevalence and load of airway bacteria in stable and exacerbated chronic obstructive pulmonary disease (COPD) has been previously studied using microbiological culture. Molecular techniques, such as quantitative PCR (qPCR), may be more informative. Methods In this study, 373 sputum samples from 134 COPD outpatients were assessed for prevalence and load of typical airway bacteria (Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis) by multiplex qPCR, with 176 samples analysed for atypical bacteria. Paired stable and exacerbation typical bacteria data were compared in 52 patients. We compared routine culture with qPCR in 177/373 samples. Results Typical bacteria were more prevalent in exacerbation than stable-state paired samples: 30/52 (57.7%) vs. 14/52 (26.9%); p=0.001. In patients who were bacteria-positive at both time points, mean (±1 SEM) load was significantly higher at exacerbation than stable state (108.5(±0.3) vs. 107.2(±0.5) cfu/ml), constituting a 20-fold increase (p=0.011). qPCR was more discriminatory at detecting typical bacteria than microbiological culture (prevalence 59.3% vs. 24.3%; p<0.001). At stable state, higher airway bacterial load correlated with more severe airflow limitation (FEV1%predicted) (r=−0.299; p=0.033) and higher inhaled corticosteroid dosage (r=0.382; p=0.008). Mean C-reactive protein was higher in bacterial-associated exacerbations (35.0 Vs 25.1 mg/L; p=0.032). Conclusions Airway bacterial prevalence and load increase at COPD exacerbations and are an aetiological factor. qPCR is more discriminatory than culture, identifying higher airway bacterial prevalence. Exacerbations associated with bacterial detection showed a higher mean C-reactive protein level. In the stable state, airway bacterial load is related to more severe airflow limitation and higher inhaled corticosteroid dosage used. Background Prevalence and load of airway bacteria in stable and exacerbated chronic obstructive pulmonary disease (COPD) has been previously studied using microbiological culture. Molecular techniques, such as quantitative PCR (qPCR), may be more informative. Methods In this study, 373 sputum samples from 134 COPD outpatients were assessed for prevalence and load of typical airway bacteria (Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis) by multiplex qPCR, with 176 samples analysed for atypical bacteria. Paired stable and exacerbation typical bacteria data were compared in 52 patients. We compared routine culture with qPCR in 177/373 samples. Results Typical bacteria were more prevalent in exacerbation than stable-state paired samples: 30/52 (57.7%) vs. 14/52 (26.9%); p=0.001. In patients who were bacteria-positive at both time points, mean (±1 SEM) load was significantly higher at exacerbation than stable state (108.5(±0.3) vs. 107.2(±0.5) cfu/ml), constituting a 20-fold increase (p=0.011). qPCR was more discriminatory at detecting typical bacteria than microbiological culture (prevalence 59.3% vs. 24.3%; p<0.001). At stable state, higher airway bacterial load correlated with more severe airflow limitation (FEV1 %predicted) (r=-0.299; p=0.033) and higher inhaled corticosteroid dosage (r=0.382; p=0.008). Mean C-reactive protein was higher in bacterial-associated exacerbations (35.0 Vs 25.1 mg/L; p=0.032). Conclusions Airway bacterial prevalence and load increase at COPD exacerbations and are an aetiological factor. qPCR is more discriminatory than culture, identifying higher airway bacterial prevalence. Exacerbations associated with bacterial detection showed a higher mean C-reactive protein level. In the stable state, airway bacterial load is related to more severe airflow limitation and higher inhaled corticosteroid dosage used. BackgroundPrevalence and load of airway bacteria in stable and exacerbated chronic obstructive pulmonary disease (COPD) has been previously studied using microbiological culture. Molecular techniques, such as quantitative PCR (qPCR), may be more informative.MethodsIn this study, 373 sputum samples from 134 COPD outpatients were assessed for prevalence and load of typical airway bacteria (Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis) by multiplex qPCR, with 176 samples analysed for atypical bacteria. Paired stable and exacerbation typical bacteria data were compared in 52 patients. We compared routine culture with qPCR in 177/373 samples.ResultsTypical bacteria were more prevalent in exacerbation than stable-state paired samples: 30/52 (57.7%) vs. 14/52 (26.9%); p=0.001. In patients who were bacteria-positive at both time points, mean ( plus or minus 1 SEM) load was significantly higher at exacerbation than stable state (108.5( plus or minus 0.3) vs. 107.2( plus or minus 0.5) cfu/ml), constituting a 20-fold increase (p=0.011). qPCR was more discriminatory at detecting typical bacteria than microbiological culture (prevalence 59.3% vs. 24.3%; p<0.001). At stable state, higher airway bacterial load correlated with more severe airflow limitation (FEV1%predicted) (r=-0.299; p=0.033) and higher inhaled corticosteroid dosage (r=0.382; p=0.008). Mean C-reactive protein was higher in bacterial-associated exacerbations (35.0 Vs 25.1 mg/L; p=0.032).ConclusionsAirway bacterial prevalence and load increase at COPD exacerbations and are an aetiological factor. qPCR is more discriminatory than culture, identifying higher airway bacterial prevalence. Exacerbations associated with bacterial detection showed a higher mean C-reactive protein level. In the stable state, airway bacterial load is related to more severe airflow limitation and higher inhaled corticosteroid dosage used. Prevalence and load of airway bacteria in stable and exacerbated chronic obstructive pulmonary disease (COPD) has been previously studied using microbiological culture. Molecular techniques, such as quantitative PCR (qPCR), may be more informative. In this study, 373 sputum samples from 134 COPD outpatients were assessed for prevalence and load of typical airway bacteria (Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis) by multiplex qPCR, with 176 samples analysed for atypical bacteria. Paired stable and exacerbation typical bacteria data were compared in 52 patients. We compared routine culture with qPCR in 177/373 samples. Typical bacteria were more prevalent in exacerbation than stable-state paired samples: 30/52 (57.7%) vs. 14/52 (26.9%); p=0.001. In patients who were bacteria-positive at both time points, mean (±1 SEM) load was significantly higher at exacerbation than stable state (108.5(±0.3) vs. 107.2(±0.5) cfu/ml), constituting a 20-fold increase (p=0.011). qPCR was more discriminatory at detecting typical bacteria than microbiological culture (prevalence 59.3% vs. 24.3%; p<0.001). At stable state, higher airway bacterial load correlated with more severe airflow limitation (FEV(1)%predicted) (r=-0.299; p=0.033) and higher inhaled corticosteroid dosage (r=0.382; p=0.008). Mean C-reactive protein was higher in bacterial-associated exacerbations (35.0 Vs 25.1 mg/L; p=0.032). Airway bacterial prevalence and load increase at COPD exacerbations and are an aetiological factor. qPCR is more discriminatory than culture, identifying higher airway bacterial prevalence. Exacerbations associated with bacterial detection showed a higher mean C-reactive protein level. In the stable state, airway bacterial load is related to more severe airflow limitation and higher inhaled corticosteroid dosage used. Prevalence and load of airway bacteria in stable and exacerbated chronic obstructive pulmonary disease (COPD) has been previously studied using microbiological culture. Molecular techniques, such as quantitative PCR (qPCR), may be more informative.BACKGROUNDPrevalence and load of airway bacteria in stable and exacerbated chronic obstructive pulmonary disease (COPD) has been previously studied using microbiological culture. Molecular techniques, such as quantitative PCR (qPCR), may be more informative.In this study, 373 sputum samples from 134 COPD outpatients were assessed for prevalence and load of typical airway bacteria (Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis) by multiplex qPCR, with 176 samples analysed for atypical bacteria. Paired stable and exacerbation typical bacteria data were compared in 52 patients. We compared routine culture with qPCR in 177/373 samples.METHODSIn this study, 373 sputum samples from 134 COPD outpatients were assessed for prevalence and load of typical airway bacteria (Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis) by multiplex qPCR, with 176 samples analysed for atypical bacteria. Paired stable and exacerbation typical bacteria data were compared in 52 patients. We compared routine culture with qPCR in 177/373 samples.Typical bacteria were more prevalent in exacerbation than stable-state paired samples: 30/52 (57.7%) vs. 14/52 (26.9%); p=0.001. In patients who were bacteria-positive at both time points, mean (±1 SEM) load was significantly higher at exacerbation than stable state (108.5(±0.3) vs. 107.2(±0.5) cfu/ml), constituting a 20-fold increase (p=0.011). qPCR was more discriminatory at detecting typical bacteria than microbiological culture (prevalence 59.3% vs. 24.3%; p<0.001). At stable state, higher airway bacterial load correlated with more severe airflow limitation (FEV(1)%predicted) (r=-0.299; p=0.033) and higher inhaled corticosteroid dosage (r=0.382; p=0.008). Mean C-reactive protein was higher in bacterial-associated exacerbations (35.0 Vs 25.1 mg/L; p=0.032).RESULTSTypical bacteria were more prevalent in exacerbation than stable-state paired samples: 30/52 (57.7%) vs. 14/52 (26.9%); p=0.001. In patients who were bacteria-positive at both time points, mean (±1 SEM) load was significantly higher at exacerbation than stable state (108.5(±0.3) vs. 107.2(±0.5) cfu/ml), constituting a 20-fold increase (p=0.011). qPCR was more discriminatory at detecting typical bacteria than microbiological culture (prevalence 59.3% vs. 24.3%; p<0.001). At stable state, higher airway bacterial load correlated with more severe airflow limitation (FEV(1)%predicted) (r=-0.299; p=0.033) and higher inhaled corticosteroid dosage (r=0.382; p=0.008). Mean C-reactive protein was higher in bacterial-associated exacerbations (35.0 Vs 25.1 mg/L; p=0.032).Airway bacterial prevalence and load increase at COPD exacerbations and are an aetiological factor. qPCR is more discriminatory than culture, identifying higher airway bacterial prevalence. Exacerbations associated with bacterial detection showed a higher mean C-reactive protein level. In the stable state, airway bacterial load is related to more severe airflow limitation and higher inhaled corticosteroid dosage used.CONCLUSIONSAirway bacterial prevalence and load increase at COPD exacerbations and are an aetiological factor. qPCR is more discriminatory than culture, identifying higher airway bacterial prevalence. Exacerbations associated with bacterial detection showed a higher mean C-reactive protein level. In the stable state, airway bacterial load is related to more severe airflow limitation and higher inhaled corticosteroid dosage used. |
Author | Garcha, Davinder S Donaldson, Gavin C Mackay, Alexander J Thurston, Sarah J Patel, Anant R C McHugh, Timothy D Goldring, James J P Wedzicha, Jadwiga A |
Author_xml | – sequence: 1 givenname: Davinder S surname: Garcha fullname: Garcha, Davinder S email: davinder.garcha.09@ucl.ac.uk organization: Centre for Respiratory Medicine, University College London, London, UK – sequence: 2 givenname: Sarah J surname: Thurston fullname: Thurston, Sarah J email: davinder.garcha.09@ucl.ac.uk organization: Centre for Respiratory Medicine, University College London, London, UK – sequence: 3 givenname: Anant R C surname: Patel fullname: Patel, Anant R C email: davinder.garcha.09@ucl.ac.uk organization: Centre for Respiratory Medicine, University College London, London, UK – sequence: 4 givenname: Alexander J surname: Mackay fullname: Mackay, Alexander J email: davinder.garcha.09@ucl.ac.uk organization: Centre for Respiratory Medicine, University College London, London, UK – sequence: 5 givenname: James J P surname: Goldring fullname: Goldring, James J P email: davinder.garcha.09@ucl.ac.uk organization: Centre for Respiratory Medicine, University College London, London, UK – sequence: 6 givenname: Gavin C surname: Donaldson fullname: Donaldson, Gavin C email: davinder.garcha.09@ucl.ac.uk organization: Centre for Respiratory Medicine, University College London, London, UK – sequence: 7 givenname: Timothy D surname: McHugh fullname: McHugh, Timothy D email: davinder.garcha.09@ucl.ac.uk organization: Centre for Clinical Microbiology, University College London, London, UK – sequence: 8 givenname: Jadwiga A surname: Wedzicha fullname: Wedzicha, Jadwiga A email: davinder.garcha.09@ucl.ac.uk organization: Centre for Respiratory Medicine, University College London, London, UK |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26635404$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22863758$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkl9v0zAUxS00xLrBRwBZQki8BK6T2HHE0xRgIAarEH8erRvH6VxSp7Pd0X17XNINaS_jxZas3zn3-ugckQM3OkPIUwavGCvE63gxetwu3ZDlwPLdUeflAzJjpZBZkdfigMwASshEUYlDchTCEgAkY9UjcpjnMj1zOSOL5gLdwgRqHV17c4WDcdpQdB0dRuzo2FO0_jde0xZ1NN4i3QTrFvRygy7aiNFeGTpvvu4MQsR2mMRmi9r4FqPpaHM-f_uYPOxxCObJ_j4m39-_-9Z8yM7OTz82J2dZK3IeswpkYaBsq5oXXLKuq4GBFtDpjum2gh4q7AQvhOi50XVdlr2UrGKIumesx-KYvJx813683JgQ1coGbYYBnRk3QTHOWZokgN-PJl_JOeQioc_voMtx4136iGKVZDIXKf9EPdtTm3ZlOrX2doX-Wt2knYAXewCDxqH36LQN_zghCl5Cmbg3E6f9GII3vdJ_kx5d9GgHxUDtOqBuO6B2HVBTB5Ka31HfDLhPl006G6LZ3orQ_1KiSvurLz8axT-dznn5-adqEg8T366W_zniD5VR1PI |
CODEN | THORA7 |
CitedBy_id | crossref_primary_10_1016_j_pupt_2014_05_002 crossref_primary_10_1016_j_spinee_2015_11_021 crossref_primary_10_1016_S0992_5945_12_71051_6 crossref_primary_10_1136_thoraxjnl_2016_209023 crossref_primary_10_1111_resp_13722 crossref_primary_10_1183_09031936_00041914 crossref_primary_10_12968_pnur_2014_25_4_180 crossref_primary_10_1111_cea_12809 crossref_primary_10_1152_ajplung_00330_2013 crossref_primary_10_1164_rccm_201910_2047ED crossref_primary_10_1016_j_ajpath_2019_05_012 crossref_primary_10_1183_09031936_00020015 crossref_primary_10_1093_cid_ciu820 crossref_primary_10_1016_j_med_2022_05_013 crossref_primary_10_1186_s12967_021_02788_4 crossref_primary_10_1080_07853890_2020_1831050 crossref_primary_10_1186_2213_0802_1_13 crossref_primary_10_1093_femsre_fuy045 crossref_primary_10_1016_j_rmr_2017_03_005 crossref_primary_10_1038_s41385_022_00541_8 crossref_primary_10_17925_USPRD_2020_5_1_18 crossref_primary_10_1136_thoraxjnl_2015_207194 crossref_primary_10_2147_COPD_S247130 crossref_primary_10_1007_s15010_019_01350_1 crossref_primary_10_1016_j_arbr_2020_08_006 crossref_primary_10_1136_bmjopen_2020_043014 crossref_primary_10_3390_biomedicines9101337 crossref_primary_10_1016_j_nhtm_2015_09_002 crossref_primary_10_3389_fmicb_2021_781797 crossref_primary_10_1111_resp_13032 crossref_primary_10_1164_rccm_201412_2269OC crossref_primary_10_1183_09031936_00191513 crossref_primary_10_3390_pharmaceutics13020177 crossref_primary_10_1136_bmjresp_2022_001335 crossref_primary_10_1016_j_vaccine_2019_07_100 crossref_primary_10_15172_pneu_2015_6_520 crossref_primary_10_1136_thoraxjnl_2019_214168 crossref_primary_10_1183_23120541_00200_2020 crossref_primary_10_3310_hta24150 crossref_primary_10_1517_14740338_2015_1057494 crossref_primary_10_1097_BRS_0000000000001389 crossref_primary_10_1080_1040841X_2017_1329274 crossref_primary_10_1016_S2213_2600_12_70063_2 crossref_primary_10_3390_vaccines9030261 crossref_primary_10_1038_mi_2013_77 crossref_primary_10_1183_23120541_00027_2016 crossref_primary_10_1159_000507228 crossref_primary_10_1016_j_jacig_2023_100194 crossref_primary_10_1080_02770903_2020_1857395 crossref_primary_10_1136_bmjresp_2021_001067 crossref_primary_10_1080_23744235_2022_2092648 crossref_primary_10_1038_cti_2017_6 crossref_primary_10_1183_13993003_00361_2015 crossref_primary_10_1164_rccm_202302_0222OC crossref_primary_10_1016_j_jaip_2017_05_024 crossref_primary_10_1164_rccm_202109_2024ED crossref_primary_10_1007_s15010_015_0833_3 crossref_primary_10_1183_20734735_0099_2024 crossref_primary_10_3390_biomedicines10102611 crossref_primary_10_1016_S2213_2600_13_70211_X crossref_primary_10_1111_crj_12671 crossref_primary_10_1016_j_ccm_2013_09_009 crossref_primary_10_1183_09031936_00092214 crossref_primary_10_3389_fphys_2017_00115 crossref_primary_10_1097_CM9_0000000000000677 crossref_primary_10_1186_s12931_014_0114_1 crossref_primary_10_5897_JMPR2015_5910 crossref_primary_10_1002_cdt3_66 crossref_primary_10_1136_bmjopen_2013_004546 crossref_primary_10_1152_ajplung_00253_2019 crossref_primary_10_3390_ijms21093044 crossref_primary_10_4104_pcrj_2013_00074 crossref_primary_10_1186_s13063_017_2144_8 crossref_primary_10_2147_COPD_S330817 crossref_primary_10_3389_fmicb_2022_1098133 crossref_primary_10_1016_j_rmed_2024_107692 crossref_primary_10_1016_j_rmed_2025_108025 crossref_primary_10_1186_s43162_021_00094_5 crossref_primary_10_1097_MCP_0b013e32835cfff5 crossref_primary_10_1016_j_eclinm_2020_100427 crossref_primary_10_1164_rccm_201712_2506OC crossref_primary_10_1186_s12931_021_01653_8 crossref_primary_10_2147_COPD_S371958 crossref_primary_10_1177_1479972316643698 crossref_primary_10_1186_1741_7015_11_181 crossref_primary_10_1513_AnnalsATS_201310_350OC crossref_primary_10_1016_j_rmed_2015_05_020 crossref_primary_10_2174_1573398X14666181018101021 crossref_primary_10_1016_j_ccm_2013_09_012 crossref_primary_10_1016_j_jaci_2020_02_040 crossref_primary_10_1038_nrd4025 crossref_primary_10_1038_s41598_021_89881_2 crossref_primary_10_1586_17476348_2016_1151789 crossref_primary_10_1371_journal_pone_0149095 crossref_primary_10_4104_pcrj_2013_00048 crossref_primary_10_3390_biomedicines10081949 crossref_primary_10_1186_s12931_017_0559_0 crossref_primary_10_1371_journal_pone_0135199 crossref_primary_10_1016_j_rmed_2024_107586 crossref_primary_10_1111_all_14058 crossref_primary_10_1590_S1806_37132013000300001 crossref_primary_10_1016_j_arbres_2020_04_023 crossref_primary_10_1183_16000617_0084_2023 crossref_primary_10_3389_fvets_2020_608901 crossref_primary_10_1183_09031936_00223113 crossref_primary_10_1183_13993003_02273_2017 crossref_primary_10_1183_13993003_00451_2017 crossref_primary_10_1183_13993003_00328_2018 crossref_primary_10_2147_COPD_S301622 crossref_primary_10_2147_COPD_S405310 crossref_primary_10_1111_resp_12709 crossref_primary_10_1111_ijcp_12535 crossref_primary_10_1183_23120541_00057_2022 crossref_primary_10_1186_s12931_017_0570_5 crossref_primary_10_12677_ACM_2022_1271003 crossref_primary_10_1177_1753465816630208 crossref_primary_10_1164_rccm_201306_1170OC crossref_primary_10_1183_16000617_0199_2020 crossref_primary_10_1186_cc13148 crossref_primary_10_1097_MCP_0000000000000154 crossref_primary_10_1177_2051013617691041 crossref_primary_10_1007_s11908_014_0444_7 crossref_primary_10_1183_13993003_01225_2018 crossref_primary_10_1378_chest_14_0764 crossref_primary_10_1371_journal_pone_0177931 crossref_primary_10_1111_resp_12734 crossref_primary_10_1513_AnnalsATS_201307_212MG crossref_primary_10_1016_j_canlet_2017_11_036 crossref_primary_10_1016_j_rmed_2019_08_012 crossref_primary_10_1038_mi_2014_95 crossref_primary_10_1080_14740338_2018_1448786 crossref_primary_10_1155_2018_2349045 crossref_primary_10_3390_biomedicines9101312 crossref_primary_10_1111_crj_13286 crossref_primary_10_1186_s12890_017_0384_8 crossref_primary_10_4046_trd_2018_0030 crossref_primary_10_1016_S2213_2600_14_70169_9 crossref_primary_10_1016_j_cbi_2019_108732 crossref_primary_10_1183_09031936_00005415 crossref_primary_10_3390_biom12101481 crossref_primary_10_3390_ijms24044086 crossref_primary_10_3389_fmicb_2022_818281 crossref_primary_10_1007_s10875_013_9942_x crossref_primary_10_1186_s12931_020_01552_4 crossref_primary_10_1371_journal_pone_0165553 crossref_primary_10_1183_23120541_00595_2023 crossref_primary_10_1016_j_jtbi_2014_04_010 crossref_primary_10_1183_13993003_01582_2017 |
ContentType | Journal Article |
Copyright | Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2014 INIST-CNRS Copyright: 2012 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions |
Copyright_xml | – notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions – notice: 2014 INIST-CNRS – notice: Copyright: 2012 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions |
DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR BTHHO CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 7QL C1K |
DOI | 10.1136/thoraxjnl-2012-201924 |
DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central BMJ Journals ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) BMJ Journals Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management |
DatabaseTitleList | ProQuest One Academic Middle East (New) Bacteriology Abstracts (Microbiology B) MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1468-3296 |
EndPage | 1080 |
ExternalDocumentID | 4027206811 22863758 26635404 10_1136_thoraxjnl_2012_201924 ark_67375_NVC_5KGP54MW_C thoraxjnl |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | London United Kingdom--UK |
GeographicLocations_xml | – name: London – name: United Kingdom--UK |
GrantInformation_xml | – fundername: Medical Research Council grantid: G0902006 – fundername: Medical Research Council grantid: G0800570 |
GroupedDBID | --- .55 .GJ .VT 08G 0R~ 123 18M 29Q 2WC 354 39C 3O- 4.4 40O 53G 5RE 5VS 6PF 7X7 7~S 88E 8F7 8FI 8FJ 8R4 8R5 AAHLL AAKAS AAOJX AAWJN AAWTL AAYEP ABAAH ABJNI ABKDF ABMQD ABOCM ABTFR ABUWG ABVAJ ACGFO ACGFS ACGTL ACHTP ACMFJ ACOAB ACOFX ACQSR ACTZY ADBBV ADCEG ADZCM AENEX AFKRA AFWFF AGQPQ AHMBA AHNKE AHQMW AJYBZ ALIPV ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF AZFZN BAWUL BENPR BLJBA BOMFT BPHCQ BTFSW BTHHO BVXVI C45 CAG CCPQU COF CS3 CXRWF DIK DU5 E3Z EBS EJD F5P FEDTE FYUFA GX1 H13 HAJ HMCUK HVGLF HYE HZ~ IAO IEA IH2 IHR IOF ITC J5H KQ8 L7B M1P N4W N9A NTWIH NXWIF O9- OK1 OVD P2P PHGZT PQQKQ PROAC PSQYO Q2X R53 RHI RMJ RPM RV8 TEORI TR2 UAW UKHRP UYXKK V24 VM9 VVN W8F WH7 X7M YFH YOC YQY ZCG ZGI 3V. BSCLL RHF AAYXX ACQHZ ADGHP AERUA CITATION PHGZM IQODW PJZUB PPXIY CGR CUY CVF ECM EIF NPM 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 7QL C1K |
ID | FETCH-LOGICAL-b625t-7083e04b7953581dd9010c60dcd1cb70f07ad65366f5ec9944f88171aacf11fa3 |
IEDL.DBID | 7X7 |
ISSN | 0040-6376 1468-3296 |
IngestDate | Thu Jul 10 21:56:18 EDT 2025 Mon Jul 21 11:07:28 EDT 2025 Fri Jul 25 06:17:43 EDT 2025 Mon Jul 21 05:50:40 EDT 2025 Mon Jul 21 09:15:27 EDT 2025 Tue Jul 01 02:00:25 EDT 2025 Thu Apr 24 22:57:50 EDT 2025 Wed Oct 30 09:48:00 EDT 2024 Thu Apr 24 23:02:51 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | Lung disease Load Prevalence Respiratory disease Change Polymerase chain reaction Respiratory tract Chronic Bronchus disease Anesthesia Bacteria Chronic obstructive pulmonary disease Circulatory system Obstructive pulmonary disease Molecular biology Cardiology Quantitative analysis |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b625t-7083e04b7953581dd9010c60dcd1cb70f07ad65366f5ec9944f88171aacf11fa3 |
Notes | local:thoraxjnl;67/12/1075 PMID:22863758 ark:/67375/NVC-5KGP54MW-C istex:F4B128648B7CAA97FB48D2B9A79E68EDCB68C9D6 href:thoraxjnl-67-1075.pdf ArticleID:thoraxjnl-2012-201924 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
OpenAccessLink | https://thorax.bmj.com/content/thoraxjnl/67/12/1075.full.pdf |
PMID | 22863758 |
PQID | 1781826201 |
PQPubID | 2041050 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_1551625605 proquest_miscellaneous_1171855026 proquest_journals_1781826201 pubmed_primary_22863758 pascalfrancis_primary_26635404 crossref_citationtrail_10_1136_thoraxjnl_2012_201924 crossref_primary_10_1136_thoraxjnl_2012_201924 istex_primary_ark_67375_NVC_5KGP54MW_C bmj_primary_10_1136_thoraxjnl_2012_201924 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-12-01 |
PublicationDateYYYYMMDD | 2012-12-01 |
PublicationDate_xml | – month: 12 year: 2012 text: 2012-12-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Thorax |
PublicationTitleAlternate | Thorax |
PublicationYear | 2012 |
Publisher | BMJ Publishing Group Ltd and British Thoracic Society BMJ Publishing Group BMJ Publishing Group LTD |
Publisher_xml | – name: BMJ Publishing Group Ltd and British Thoracic Society – name: BMJ Publishing Group – name: BMJ Publishing Group LTD |
References | Wedzicha, Seemungal 2007; 370 Taylor, Finney-Hayward, Quint 2010; 35 Diederen, van der Valk, Kluytmans 2007; 30 Abdeldaim, Strålin, Olcén 2008; 60 Mathers, Loncar 2006; 3 Wilkinson, Patel, Wilks 2003; 167 Lieberman, Lieberman, Shmarkov 2002; 19 Lieberman, Ben-Yaakov, Lazarovich 2001; 20 Monso, Ruiz, Rosell 1995; 152 Daniels, Schoorl, Snijders 2010; 138 Erb-Downward, Thompson, Han 2011; 6 Wedzicha, Calverley, Seemungal 2008; 177 Larsen, Steen-Jensen, Laursen 2012; 7 Murphy, Brauer, Schiffmacher 2004; 170 Wilkinson, Hurst, Perera 2006; 129 Sethi, Evans, Grant 2002; 347 Rosell, Monsó, Soler 2005; 165 Patel, Seemungal, Wilks 2002; 57 Seemungal, Donaldson, Paul 1998; 157 Salcedo, Cid 2011; 157 Hilty, Burke, Pedro 2010; 5 Welti, Jaton, Altwegg 2003; 45 Papi, Bellettato, Braccioni 2006; 173 Nolan, Hands, Ogunkolade 2006; 351 Hurst, Donaldson, Perera 2006; 174 Miravitlles, Espinosa, Fernández-Laso 1999; 116 Rabe, Hurd, Anzueto 2007; 176 White, Gompertz, Bayley 2003; 58 Calverley, Anderson, Celli 2007; 356 Calverley, Stockley, Seemungal 2011; 139 Huang, Kim, Cox 2010; 14 Hill, Campbell, Hill 2000; 109 Greiner, Day, Altwegg 2003; 41 Curran, Coyle, McManus 2007; 50 |
References_xml | – volume: 30 start-page: 240 year: 2007 article-title: The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease publication-title: Eur Respir J – volume: 35 start-page: 1039 year: 2010 article-title: Defective macrophage phagocytosis of bacteria in COPD publication-title: Eur Respir J – volume: 109 start-page: 288 year: 2000 article-title: Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis publication-title: Am J Med – volume: 174 start-page: 867 year: 2006 article-title: Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease publication-title: Am J Respir Crit Care Med – volume: 116 start-page: 40 year: 1999 article-title: Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD* publication-title: Chest – volume: 45 start-page: 85 year: 2003 article-title: Development of a multiplex real-time quantitative PCR assay to detect Chlamydia pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae in respiratory tract secretions publication-title: Diagn Microbiol Infect Dis – volume: 176 start-page: 532 year: 2007 article-title: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary publication-title: Am J Respir Crit Care Med – volume: 173 start-page: 1114 year: 2006 article-title: Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations publication-title: Am J Respir Crit Care Med – volume: 170 start-page: 266 year: 2004 article-title: Persistent colonization by haemophilus influenzae in chronic obstructive pulmonary disease publication-title: Am J Respir Crit Care Med – volume: 177 start-page: 19 year: 2008 article-title: The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide publication-title: Am J Respir Crit Care Med – volume: 57 start-page: 759 year: 2002 article-title: Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations publication-title: Thorax – volume: 370 start-page: 786 year: 2007 article-title: COPD exacerbations: defining their cause and prevention publication-title: Lancet – volume: 138 start-page: 1108 year: 2010 article-title: Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD publication-title: Chest – volume: 3 start-page: e442 year: 2006 article-title: Projections of global mortality and burden of disease from 2002 to 2030 publication-title: PLoS Med – volume: 19 start-page: 392 year: 2002 article-title: Serological evidence of Legionella species infection in acute exacerbation of COPD publication-title: Eur Respir J – volume: 157 start-page: 1418 year: 1998 article-title: Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease publication-title: Am J Respir Crit Care Med – volume: 7 start-page: e31976 year: 2012 article-title: Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiota publication-title: PLoS One – volume: 167 start-page: 1090 year: 2003 article-title: Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease publication-title: Am J Respir Crit Care Med – volume: 351 start-page: 308 year: 2006 article-title: SPUD: a quantitative PCR assay for the detection of inhibitors in nucleic acid preparations publication-title: Anal Biochem – volume: 20 start-page: 698 year: 2001 article-title: Chlamydia pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease: analysis of 250 hospitalizations publication-title: Eur J Clin Microbiol Infect Dis – volume: 50 start-page: 112 year: 2007 article-title: Evaluation of real-time PCR for the detection and quantification of bacteria in chronic obstructive pulmonary disease publication-title: FEMS Immunol Med Microbiol – volume: 60 start-page: 143 year: 2008 article-title: Toward a quantitative DNA-based definition of pneumococcal pneumonia: a comparison of Streptococcus pneumoniae target genes, with special reference to the Spn9802 fragment publication-title: Diagn Microbiol Infect Dis – volume: 152 start-page: 1316 year: 1995 article-title: Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush publication-title: Am J Respir Crit Care Med – volume: 6 start-page: e16384 year: 2011 article-title: Analysis of the lung microbiome in the “Healthy” Smoker and in COPD publication-title: PLoS One – volume: 5 start-page: e8578 year: 2010 article-title: Disordered microbial communities in asthmatic airways publication-title: PLoS One – volume: 165 start-page: 891 year: 2005 article-title: Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease publication-title: Arch Intern Med – volume: 129 start-page: 317 year: 2006 article-title: Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD* publication-title: Chest – volume: 58 start-page: 680 year: 2003 article-title: Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis publication-title: Thorax – volume: 157 start-page: 1 year: 2011 article-title: Nontypable Haemophilus influenzae: an intracellular phase within epithelial cells might contribute to persistence publication-title: Microbiology – volume: 347 start-page: 465 year: 2002 article-title: New strains of bacteria and exacerbations of chronic obstructive pulmonary disease publication-title: N Engl J Med – volume: 139 start-page: 505 year: 2011 article-title: Reported pneumonia in patients with COPD: findings from the INSPIRE study publication-title: Chest – volume: 41 start-page: 1386 year: 2003 article-title: Quantitative detection of Moraxella catarrhalis in nasopharyngeal secretions by real-time PCR publication-title: J Clin Microbiol – volume: 356 start-page: 775 year: 2007 article-title: Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease publication-title: N Engl J Med – volume: 14 start-page: 9 year: 2010 article-title: A Persistent and Diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations publication-title: OMICS |
SSID | ssj0008117 |
Score | 2.4867039 |
Snippet | Background Prevalence and load of airway bacteria in stable and exacerbated chronic obstructive pulmonary disease (COPD) has been previously studied using... Prevalence and load of airway bacteria in stable and exacerbated chronic obstructive pulmonary disease (COPD) has been previously studied using microbiological... BackgroundPrevalence and load of airway bacteria in stable and exacerbated chronic obstructive pulmonary disease (COPD) has been previously studied using... |
SourceID | proquest pubmed pascalfrancis crossref istex bmj |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1075 |
SubjectTerms | Aged Analysis of Variance Bacteria bacterial load Batch processing Biological and medical sciences Cardiology. Vascular system Chi-Square Distribution Chronic obstructive pulmonary disease Chronic obstructive pulmonary disease, asthma colonisation COPD Dyspnea exacerbations Female Haemophilus influenzae Haemophilus influenzae - isolation & purification Humans Inflammation Linear Models London Male Medical sciences Moraxella catarrhalis Moraxella catarrhalis - isolation & purification Mortality Pneumology Polymerase Chain Reaction - methods Prevalence Proteins Pulmonary Disease, Chronic Obstructive - microbiology Pulmonary Disease, Chronic Obstructive - physiopathology quantitative PCR Respiratory Function Tests Sputum - microbiology Staphylococcus infections Steroids Streptococcus pneumoniae Streptococcus pneumoniae - isolation & purification |
Title | Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD |
URI | https://thorax.bmj.com/content/67/12/1075.full https://api.istex.fr/ark:/67375/NVC-5KGP54MW-C/fulltext.pdf https://www.ncbi.nlm.nih.gov/pubmed/22863758 https://www.proquest.com/docview/1781826201 https://www.proquest.com/docview/1171855026 https://www.proquest.com/docview/1551625605 |
Volume | 67 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLbYKiFeEPcFRmUkhMRDWJw4jv2EIOwiUEs1Meib5fgytnVJ17Si_Ht8kjTTHhi8RIpiO9a52N-xzwWh1zY2PKPchY5ZEVLj10HBDA0T6yKhSSFcDPHOozE7OqGfp-m0O3CrO7fKzZrYLNSm0nBGvkcyDlDY71fv51chVI2C29WuhMYWGkDqMjC-smlvcEUQRLnxmmNek7oIHpKwveVPT-H1eTnzYkJieAgIet8qLs9v7FADIPYaPCZV7Ynm2moXf4ejzbZ08ADd7_Ak_tAKwEN0x5aP0N1Rd2P-GJ224QM1PivxfAG5vUGVsSoNnlXK4Mphdbb4pX7jos3brDC4wp_iq5UqmwA0vxziSX4MA3gkWczaznattOeIR6oG518nn56gk4P9b_lR2BVXCAtv8izDzGMvG9EiEymkQDMG_DQ0i4w2RBdZ5KJMGZYmjLnUaiEodZyTjCilHSFOJU_RdlmVdgdhxgthuWXWoxMaGS6cEpQnkbAqZloXAXrrySrnbfoM2ZgdCZM9CySwQLYsCBDdEF_qLks5FMuY_avbu77bf_7nTcPZvrVaXICPW5bK8fdcpl8OJykd_ZB5gIY3WN93iAGr0ciPtLuRBdnpfy2vpTVAr_rPXnPhOkaVtlrVkGadQDq5mN3SBu4xAZWmAXrWytn1BGLuhTrlz2-fwAt0rxHxxgVnF20vFyv70gOpZTFstGWIBh_3x5Nj_3Y4JX8AvC8bsg |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1JbxMxFLa6SMAFsRMoxUiAxGHoLB6PfUAIpZSUNCFCbcnNeMZ2aQmTNIua_il-I-_NVvVA4dLLXMbPY_l7fv48fgshL21oRMKE8xy30mMG7KDkhnmRdb7MglS6EOOde33eOWCfh_FwhfyuY2HQrbK2iYWhNuMM_5FvBYlAKgz71fvJqYdVo_B2tS6hUapF156fwZFt9m53G_B9FYY7H_fbHa-qKuClwPXnXgKkw_osTWSMub-MQQeFjPsmM0GWJr7zE214HHHuYptJyZgTIkgCrTMXBE5H0O8qWYeN10cXwmTYHPB8DNqsvfQ4rNwqYiiI-Nb8ByC6PMlHoJZBiA-JQfar6a-TSzviOoK7RA9NPQOQXFld4-_0t9gGd-6Q2xV_pR9KhbtLVmx-j9zoVTf098lRGa4wo8c5nUwxlziaDqpzQ0djbejYUX08PdPnNC3zRGuKrvdH9HSh8yLgDcwvHbS_YgfAXNNRKWyXOgMNAGZsaPvLYPsBObiWaX9I1vJxbh8TykUqrbDcAhtivhHSaclE5EurQ55laYu8gWlVkzJdhyqOORFXDQQKIVAlBC3C6slXWZUVHYtzjP4l9rYR-8_vvC6QbVrr6U_0qUti1T9sq7j7aRCz3jfVbpHNS9A3AiFyQ-ZDTxu1LqjK3szUxepokRfNa7AUeP2jcztezDCte4Dp60J-RRu8N0UWHLfIo1LPLgYQClDqWDy5egDPyc3Ofm9P7e32u0_JrULdC_efDbI2ny7sMyBx83SzWDmUfL_upfoHfhxVYA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1JbxMxFLa6SBUXxE6gFCMBEochs3g84wNCKCG0hJQIUZqb8XgpLWGSZlHTv8av473Zqh4oXHqZy9gey997z5_HbyHkuQ1NmrDUeY5b4TEDdlBww7zIOl_oIBMuxHjnwT7fPWAfR_FojfyuY2HQrbK2iYWhNhON_8jbQZIiFYb9qu0qt4hht_d2euphBSm8aa3LaZQi0rfnZ3B8m7_Z6wLWL8Kw9_5rZ9erKgx4GfD-hZcAAbE-yxIRYx4wY9BZQXPfaBPoLPGdnyjD44hzF1stBGMuTYMkUEq7IHAqgnHXyWYSwbYJupSMmsOejwGctcceBy2uooeCiLcXPwDd1Uk-BhENQnwIDLhfz36dXNodNxHoFXprqjkA5spKG3-nwsWW2LtFblZclr4rhe82WbP5HbI1qG7r75KjMnRhTo9zOp1hXnE0I1Tlho4nytCJo-p4dqbOaVbmjFYU3fCP6OlS5UXwG5hiOux8wQGAxWbjsrNdKQ3SACzZ0M7nYfceObiWZb9PNvJJbh8SytNM2NRyC8yI-SYVTgmWRr6wKuRaZy3yCpZVTsvUHbI48kRcNhBIhECWELQIqxdf6ipDOhbqGP-r2-um239-52WBbNNazX6if10Sy_1vHRn3PwxjNjiUnRbZuQR90yFEnsh8GGm7lgVZ2Z65vNCUFnnWvAargVdBKreT5RxTvAeYyi7kV7TBO1RkxHGLPCjl7GICYQpCHaePrp7AU7IFSio_7e33H5MbhbQXnkDbZGMxW9onwOcW2U6hOJR8v25N_QOexVmW |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Changes+in+prevalence+and+load+of+airway+bacteria+using+quantitative+PCR+in+stable+and+exacerbated+COPD&rft.jtitle=Thorax&rft.au=Garcha%2C+Davinder+S&rft.au=Thurston%2C+Sarah+J&rft.au=Patel%2C+Anant+R+C&rft.au=Mackay%2C+Alexander+J&rft.date=2012-12-01&rft.eissn=1468-3296&rft.volume=67&rft.issue=12&rft.spage=1075&rft_id=info:doi/10.1136%2Fthoraxjnl-2012-201924&rft_id=info%3Apmid%2F22863758&rft.externalDocID=22863758 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0040-6376&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0040-6376&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0040-6376&client=summon |